Moreover, anti-IL-6 therapies have proven especially useful for example in treating rheumatoid arthritis in patients unresponsive to TNF inhibitors (Tanaka and Martin Mola, 2014). This evidence concerns the gene IL6 and rheumatoid arthritis.